Novartis AG Claims Its Alcon, Inc. Offer Is More Attractive Now

Bloomberg -- Novartis AG indicated Alcon Inc. shareholders should take another look at its $11.5 billion buyout offer now that an increase in the Swiss drugmaker’s share price and a rally in the franc have lifted the value of the bid.